Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER.
about
Duration of trastuzumab in patients with HER2-positive metastatic breast cancer in prolonged remissionThe SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer.The Long-HER study: clinical and molecular analysis of patients with HER2+ advanced breast cancer who become long-term survivors with trastuzumab-based therapy.More than 9 years of continuous trastuzumab treatment in metastatic breast cancer without cardiac toxicity: a case report and literature review.Mild hyperthermia influence on Herceptin(®) properties.Can maintenance trastuzumab be stopped in patients with HER2-positive metastatic breast cancer?Patterns of Care and Clinical Outcomes of First-Line Trastuzumab-Based Therapy in HER2-Positive Metastatic Breast Cancer Patients Relapsing After (Neo)Adjuvant Trastuzumab: An Italian Multicenter Retrospective Cohort Study.Clinical predictors of long-term survival in HER2-positive metastatic breast cancer.Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohort.Survivorship in untreated breast cancer patients.Prognostic Factors of Survival among Women with Metastatic Breast Cancer and Impact of Primary or Secondary Nature of Disease on Survival: A French Population-Based Study.Real-World Evidence: A Comparison of the Australian Herceptin Program and Clinical Trials of Trastuzumab for HER2-Positive Metastatic Breast Cancer.Routine treatment and outcome of breast cancer in younger versus elderly patients: results from the SENORA project of the prospective German TMK cohort study.Durable complete response in HER2-positive breast cancer: a multicenter retrospective analysis.Validation of the 8th AJCC prognostic staging system for breast cancer in a population-based setting.Long-responders to anti-HER2 therapies: A case report and review of the literature.Pattern of metastatic spread and subcategories of breast cancer.Clinicopathological and surgical factors associated with long-term survival in patients with HER2-positive metastatic breast cancer.
P2860
Q26749255-7856B989-DCFB-422A-9A93-4AC2AF2F9012Q33573092-50D61B1F-2555-4B84-840C-9167525E62C0Q33683344-440D9719-4EDD-4F0A-88C4-0249E4C2EACEQ34373936-2B1041A6-9C56-4A62-B248-6CCE2CE31E76Q34394390-A013EA0D-3C4B-4A6A-95B5-7C0A8E372DE4Q35184811-ACF9F09B-F549-4CC9-BB73-F8B7B965468DQ35699689-84CC8BF5-515D-4BD2-8540-24F14B44820BQ35915735-CF98FBF3-4012-4B38-8813-850A07858FC8Q36974534-7D5BAB38-EA68-48C5-94F4-FE7E4B3B4E5CQ37612139-9B1AE9AD-7205-44D8-B1BB-AB0E80448768Q38318523-7FD651F2-BC0C-4537-8957-4B593EB4C6BFQ39115827-34EDB70E-CB10-4C80-AB77-638AF0445729Q39748463-98B6A05E-3F8C-405C-BEBB-F4261676B30AQ47797321-D2B09871-F2B9-45E0-AF98-4AEC22C4575CQ47999034-CCFD5D11-160E-4FC5-8476-6EA88FE1D662Q48295308-B3A62620-4136-4F0D-9D65-5707ABA45DF7Q49311135-0F3D0285-02A0-4049-875F-09CA23C2B39EQ50550387-8FDAB2B5-94B9-428D-9151-26F27989286BQ51572739-787E6FDC-9389-45D6-82E7-983D96996AF5
P2860
Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Long-term survivor characteris ...... breast cancer from registHER.
@ast
Long-term survivor characteris ...... breast cancer from registHER.
@en
type
label
Long-term survivor characteris ...... breast cancer from registHER.
@ast
Long-term survivor characteris ...... breast cancer from registHER.
@en
prefLabel
Long-term survivor characteris ...... breast cancer from registHER.
@ast
Long-term survivor characteris ...... breast cancer from registHER.
@en
P2093
P2860
P356
P1476
Long-term survivor characteris ...... breast cancer from registHER.
@en
P2093
A M Brufsky
D A Yardley
D Tripathy
J Magidson
M Ulcickas Yood
P A Kaufman
P2860
P2888
P304
P356
10.1038/BJC.2014.174
P407
P577
2014-04-17T00:00:00Z
P5875
P6179
1007246393